Skip to content
PubMed This is a summary of 127 peer-reviewed journal articles Updated
Oncology · Squamous Cell Carcinoma of the Cervix

Squamous Cell Carcinoma of the Cervix: A Patient Guide

At a Glance

Cervical squamous cell carcinoma is usually linked to persistent HPV and treated according to its stage. Care may include chemoradiation with brachytherapy, fertility-sparing options for selected early cases, immunotherapy for some advanced cancers, and lifelong follow-up.

Receiving a diagnosis of squamous cell carcinoma of the cervix can feel overwhelming, but you are not alone in this journey. This condition, which begins in the thin, flat cells of the outer cervix, is the most common type of cervical cancer and is one that the medical community understands deeply [1]. While a diagnosis is a significant life event, it is important to know that many cases can be treated successfully, with clear, evidence-based paths guiding your care.

At the heart of most cervical squamous cell carcinomas is a very common virus called the human papillomavirus, or HPV. For most people, the body clears this virus on its own, but in some cases, the virus persists, slowly changing the instructions within the cervical cells over many years [2]. Because this process is typically slow, there are often many opportunities for your care team to intervene effectively.

Your path forward is guided by a process called staging, which acts as a map for your treatment. This map helps your doctors decide on the most effective approach and define the goals of your treatment—whether that is aiming for a complete cure, long-term disease control, or symptom relief. For women with carefully selected early-stage disease, it may be possible to consider treatments that preserve fertility and the ability to carry a pregnancy, ensuring that your future goals remain a central part of the discussion [3].

When the cancer has moved more deeply into the surrounding tissues, the foundation of curative-intent treatment is a specialized combination of radiation and chemotherapy. An essential component of this process is brachytherapy—a targeted form of internal radiation that delivers a powerful dose exactly where it is needed while protecting the healthy organs nearby [4][5]. Furthermore, for eligible patients with advanced or high-risk disease, modern advances like immunotherapy may be considered to continue expanding the options available [6].

Beyond the active phase of treatment lies survivorship, a lifelong commitment to monitoring your health and maintaining your quality of life. This phase focuses on follow-up exams to monitor your response to treatment and on proactively managing any long-term effects on your body [7]. Your medical team remains your partner in this journey, working to ensure that you receive comprehensive care in the years to come.

Common questions in this guide

What does the stage of cervical squamous cell carcinoma tell me?
The stage describes how far the cancer has spread and helps your doctors choose an appropriate treatment plan. It also helps define whether treatment is intended to cure the cancer, control it over the long term, or relieve symptoms.
Can treatment for early cervical cancer preserve fertility?
Some carefully selected patients with early-stage cervical cancer may be able to discuss fertility-sparing treatment or ovarian preservation. Eligibility depends on the cancer’s stage and other personal and medical factors, so ask your care team about your options.
Why are chemotherapy, radiation, and brachytherapy sometimes combined?
For cancer that has grown more deeply into surrounding tissues, treatment may combine chemotherapy with radiation. Brachytherapy is internal radiation that delivers a concentrated dose near the cancer while helping limit exposure to nearby healthy organs.
How is HPV connected to cervical squamous cell carcinoma?
Most HPV infections clear on their own, but a persistent infection can slowly change cervical cells over many years. These changes can eventually lead to cervical squamous cell carcinoma.
Could immunotherapy be part of my cervical cancer treatment?
Immunotherapy may be considered for some patients with advanced or high-risk cervical cancer. Your oncology team will determine whether it is appropriate based on your stage, overall health, and prior or planned treatments.
What follow-up is needed after cervical cancer treatment?
Survivorship care includes follow-up examinations to monitor your health and response after treatment. Your care team can also help identify and manage long-term effects that may affect your body or quality of life.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific stage of my cancer, and how does that 'map' influence the treatment goals we are discussing?
  2. 2.If I have early-stage disease, am I a candidate to discuss fertility-sparing surgeries or ovarian preservation?
  3. 3.Will my treatment involve a combination of chemoradiation and brachytherapy, and how do these work together?
  4. 4.What does my follow-up schedule look like after my active treatment is complete?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.

    Arbyn M, Weiderpass E, Bruni L, et al.

    The Lancet. Global health 2020; (8(2)):e191-e203 doi:10.1016/S2214-109X(19)30482-6.

    PMID: 31812369
  2. 2

    The natural history of human papillomavirus infection.

    de Sanjosé S, Brotons M, Pavón MA

    Best practice & research. Clinical obstetrics & gynaecology 2018; (47()):2-13 doi:10.1016/j.bpobgyn.2017.08.015.

    PMID: 28964706
  3. 3

    Management of Early Stage Cervical Cancer.

    Somashekhar SP, Ashwin KR

    Reviews on recent clinical trials 2015; (10(4)):302-8 doi:10.2174/1574887110666150923113629.

    PMID: 26411950
  4. 4

    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.

    Pötter R, Tanderup K, Schmid MP, et al.

    The Lancet. Oncology 2021; (22(4)):538-547 doi:10.1016/S1470-2045(20)30753-1.

    PMID: 33794207
  5. 5

    Differences in outcome for cervical cancer patients treated with or without brachytherapy.

    Karlsson J, Dreifaldt AC, Mordhorst LB, Sorbe B

    Brachytherapy 2017; (16(1)):133-140 doi:10.1016/j.brachy.2016.09.011.

    PMID: 27836496
  6. 6

    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

    Lorusso D, Xiang Y, Hasegawa K, et al.

    Lancet (London, England) 2024; (403(10434)):1341-1350 doi:10.1016/S0140-6736(24)00317-9.

    PMID: 38521086
  7. 7

    Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update.

    Elit L, Kennedy EB, Fyles A, Metser U

    Current oncology (Toronto, Ont.) 2016; (23(2)):109-18 doi:10.3747/co.23.2742.

    PMID: 27122975

This page is for informational purposes only and does not constitute medical advice. Your gynecologic oncology team can explain how cervical cancer staging and treatment options apply to your specific situation.

Get notified when new evidence is published on Squamous cell carcinoma of the cervix uteri.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.